2024/02/27 by Suramya Waidyanatha, Bradley J. Collins, Tim Cristy +12 · 1 voice · 1 citation
Medicine · Biochemistry, Genetics and Molecular Biology · #Complementary and Alternative Medicine Studies #Ginseng Biological Effects and Applications #Ginkgo biloba and Cashew Applications
paper · doi:10.1016/j.fct.2024.114537
openalex publication_date 2024/02/27 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/22
Increases in botanical use, encompassing herbal medicines and dietary supplements, have underlined a critical need for an advancement in safety assessment methodologies. However, botanicals present unique challenges for safety assessment due to their complex and variable composition arising from diverse growing conditions, processing methods, and plant varieties. Historically, botanicals have been largely evaluated based on their history of use information, based primarily on traditional use or dietary history. However, this presumption lacks comprehensive toxicological evaluation, demanding innovative and consistent assessment strategies. To address these challenges, the Botanical Safety Consortium (BSC) was formed as an international, cross-sector forum of experts to identify fit-for purpose assays that can be used to evaluate botanical safety. This global effort aims to assess botanical safety assessment methodologies, merging traditional knowledge with modern in vitro and in silico assays. The ultimate goal is to champion the development of toxicity tools for botanicals. This manuscript highlights: 1) BSC's strategy for botanical selection, sourcing, and preparation of extracts to be used in in vitro assays, and 2) the approach utilized to characterize botanical extracts, using green tea and Asian ginseng as examples, to build confidence for use in biological assays.